Tivic Health Systems Inc. (TIVC)
NASDAQ: TIVC
· Real-Time Price · USD
3.73
0.02 (0.54%)
At close: Jun 16, 2025, 3:59 PM
3.78
1.34%
After-hours: Jun 16, 2025, 07:44 PM EDT
Company Description
Tivic Health Systems Inc. operates as a bioelectronic device company that delivers non-invasive neuromodulation products for the treatment of inflammatory conditions.
Its primary product is ClearUP, is a medical device intended to relieve sinus and nasal inflammation.
The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, including BestBuy.com and FSAStore.com.
Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, California.
Tivic Health Systems Inc.
| Country | United States |
| IPO Date | Nov 11, 2021 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 7 |
| CEO | Jennifer Ernst |
Contact Details
Address: 25821 Industrial Boulevard Fremont, California United States | |
| Website | https://www.tivichealth.com |
Stock Details
| Ticker Symbol | TIVC |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001787740 |
| CUSIP Number | 888705100 |
| ISIN Number | US8887052095 |
| Employer ID | 81-4016391 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Jennifer Ernst | Co-Founder, Chief Executive Officer & Director |
| Lisa G. Wolf | Interim Chief Financial Officer |
| Michael Kevin Handley | Chief Operating Officer & President of Tivic Biopharma |
| Dr. Blake Gurfein Ph.D. | Chief Scientific Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 06, 2025 | S-1 | Filing |
| Jun 02, 2025 | ARS | Filing |
| Jun 02, 2025 | DEF 14A | Filing |
| May 23, 2025 | PRE 14A | Filing |
| May 22, 2025 | 8-K | Current Report |
| May 20, 2025 | 8-K | Current Report |
| May 15, 2025 | 10-Q | Quarterly Report |
| May 15, 2025 | 8-K | Current Report |
| May 14, 2025 | 8-K | Current Report |
| May 13, 2025 | 424B3 | Filing |